Sonothera closes over-subscribed $125 million Series B financing to advance clinical development
Sonothera closes their Series B financing to advance clinical development of ultrasound mediated non-viral genetic medicines.
News
listing-news
Latest News
Syntax Bio Announces Collaboration with Mayo Clinic to Advance Pancreatic Cell Therapy for Type 1 Diabetes
Collaboration seeks to accelerate translation and development of stem cell-derived pancreatic cells
Illumina Ventures Publishes Diagnostics Year in Review
For feedback or questions, contact us at info@illuminaventures.com
Illumina Ventures Welcomes DeepSeq.AI as the Newest Illumina Ventures Labs Company
DeepSeq.AI announced the completion of an investment from Illumina Ventures. As part of the investment transaction, Martin Moorhead, PhD, Chief AI Scientist at Illumina Ventures, will join the DeepSeq board.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
0 selected
Generating previews...